Cogent Biosciences (COGT) Financials: Revenue & Earnings

COGT price $32.15 +0.14 +0.42%

Ticker
COGT
Price
$32.15
Change
+0.14 +0.42%
Market cap ?
$5.58B
P/E ?
-13.52
Forward P/E ?
37.20
Dividend yield ?
0.00%
Beta ?
0.31
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
53
Quality
44
Growth
99

Stocklytics score rationale: value 53, quality 44, growth 99.

Financials

2016201720182019202020212022202320242025
63550008360000973400022499000787100000000

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced…

Fair value

COGT fair value $32.76. Price $32.15. Price is about fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare COGT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-06—-0.56—750.00K
2026-08-10-0.52-0.55—1.00K
2026-05-05-0.53-0.53—500
2026-02-17-0.55-0.51—1.68M
2025-11-07-0.50-0.54——
2025-08-05-0.53-0.55——
2025-05-06-0.52-0.56——
2025-02-25-0.61-0.59——
2024-11-12-0.64-0.55——
2024-08-06-0.59-0.55——
2024-05-07-0.62-0.50——
2024-02-26-0.63-0.545.59M—
2023-11-02-0.64-0.50——
2023-08-08-0.59-0.53——
2023-05-09-0.54-0.58——
2023-03-14-0.56-0.50——
2022-11-14-0.50-0.51——
2022-08-09-0.71-0.64——
2022-05-10-0.68-0.53——
2022-03-15-0.61-0.55——
2021-11-10-0.48-0.43——
2021-08-16-0.43-0.39——
2021-05-12-0.34-0.46——
2021-03-16-6.03-0.300—
2020-11-09-1.04-0.76312.00K1.98M
2020-08-11-0.96-0.84528.00K452.57K
2020-05-11-0.80-1.237.03M9.49M
2020-03-260.28-1.1415.29M—
2019-11-12-1.56-1.301.02M816.00K
2019-08-12-1.36-1.603.14M3.61M
2019-05-13-1.56-1.333.05M2.53M
2019-03-28-1.16-1.413.81M—
2018-11-12-1.36-1.402.04M3.47M
2018-08-13-1.24-1.381.67M1.81M
2018-05-14-2.64-1.402.22M2.06M
2018-03-29-0.95—2.33M—
2017-12-31-1.14—2.12M—
2017-06-30-0.79—2.08M—
2017-03-31-0.80—1.83M—
2016-09-30-0.77—52.18M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Ferrante Karen JeanBuy759$31.5923.98K
2026-08-27Morris ArleneBuy3.58K$2.529.03K
2026-08-27Morris ArleneBuy41.93K$5.64236.47K
2026-08-27Morris ArleneSell42.35K$37.091.57M
2026-08-27Morris ArleneSell41.93K$5.64236.47K
2026-08-27Morris ArleneSell3.16K$37.54118.66K
2026-08-27Morris ArleneSell3.58K$2.529.03K
2026-07-01Ferrante Karen JeanBuy627$38.4824.13K
2026-06-09Harwin Peter EvanBuy17.90K$31.98572.47K
2026-06-09Ferrante Karen JeanBuy17.90K$31.98572.47K
2026-06-09CAIN CHRISTOPHER W.Buy17.90K$31.98572.47K
2026-06-09Shegog ToddBuy17.90K$31.98572.47K
2026-06-09Morris ArleneBuy17.90K$31.98572.47K
2026-06-09Ros MatthewBuy17.90K$31.98572.47K
2026-05-19Robbins Andrew RSell160.00K——
2026-05-19Robbins Andrew RBuy160.00K——
2026-04-01Ferrante Karen JeanBuy686$35.2424.17K
2026-03-31Fairmount Funds Management LLCBuy7.00M$34.66242.62M
2026-03-31Fairmount Funds Management LLCSell7.00M$34.66242.62M
2026-03-31Fairmount Funds Management LLCSell28.00K——
2026-01-22Fairmount Funds Management LLCSell3.50M$36.40127.40M
2026-01-01Ferrante Karen JeanBuy643$34.7422.34K
2025-12-26Kearns EvanSell65.00K$38.702.52M
2025-12-26Green John L.Sell77.00K$38.682.98M
2025-12-26Sachs JessicaSell82.64K$38.703.20M
2025-12-26Robinson John EdwardSell90.00K$38.743.49M
2025-12-17Robinson John EdwardBuy320.00K——
2025-12-17Robinson John EdwardSell140.00K$39.455.52M
2025-12-17Robinson John EdwardBuy65.00K$39.452.56M
2025-12-17Robinson John EdwardBuy50.00K——
2025-12-17Robbins Andrew RBuy840.00K——
2025-12-17Robbins Andrew RSell367.50K$39.4514.50M
2025-12-17Robbins Andrew RBuy245.00K$39.459.67M
2025-12-17Robbins Andrew RBuy185.00K——
2025-12-17Pinnow ColeBuy214.00K——
2025-12-17Pinnow ColeSell94.80K$39.453.74M
2025-12-17Pinnow ColeBuy50.00K——
2025-12-17Pinnow ColeBuy65.00K$39.452.56M
2025-12-17Kearns EvanBuy260.00K——
2025-12-17Kearns EvanSell125.60K$39.454.95M
2025-12-17Kearns EvanBuy55.00K$39.452.17M
2025-12-17Kearns EvanBuy40.00K——
2025-12-17Sachs JessicaBuy320.00K——
2025-12-17Sachs JessicaSell154.72K$39.456.10M
2025-12-17Sachs JessicaBuy65.00K$39.452.56M
2025-12-17Sachs JessicaBuy50.00K——
2025-12-17Green John L.Buy300.00K——
2025-12-17Green John L.Sell145.01K$39.455.72M
2025-12-17Green John L.Buy65.00K$39.452.56M
2025-12-17Green John L.Buy50.00K——
2025-10-01Ferrante Karen JeanBuy1.64K$14.1323.20K
2025-07-10Fairmount Funds Management LLCBuy2.78M$9.0025.00M
2025-07-01Ferrante Karen JeanBuy3.31K$7.2223.93K
2025-06-04Ferrante Karen JeanBuy44.70K$5.64252.11K
2025-06-04CAIN CHRISTOPHER W.Buy44.70K$5.64252.11K
2025-06-04Ros MatthewBuy44.70K$5.64252.11K
2025-06-04Shegog ToddBuy44.70K$5.64252.11K
2025-06-04Harwin Peter EvanBuy44.70K$5.64252.11K
2025-06-04Morris ArleneBuy44.70K$5.64252.11K
2025-04-01Ferrante Karen JeanBuy3.79K$5.7921.93K
2025-01-23Green John L.Buy270.00K$8.892.40M
2025-01-23Pinnow ColeBuy240.00K$8.892.13M
2025-01-23Robinson John EdwardBuy270.00K$8.892.40M
2025-01-23Sachs JessicaBuy270.00K$8.892.40M
2025-01-23Robbins Andrew RBuy915.00K$8.898.13M
2025-01-23Kearns EvanBuy230.00K$8.892.04M
2025-01-14Pinnow ColeBuy43.75K$7.60332.41K
2025-01-01Ferrante Karen JeanBuy2.79K$7.8021.72K
2024-10-01Ferrante Karen JeanBuy2.03K$10.7521.87K
2024-07-01Ferrante Karen JeanBuy2.46K$8.9422.01K
2024-06-10Fairmount Funds Management LLCBuy1.50M$0.001.50K
2024-06-10Fairmount Funds Management LLCSell1.50K——
2024-06-05CAIN CHRISTOPHER W.Buy44.70K$8.92398.72K
2024-06-05Ros MatthewBuy44.70K$8.92398.72K
2024-06-05Ferrante Karen JeanBuy44.70K$8.92398.72K
2024-06-05Harwin Peter EvanBuy44.70K$8.92398.72K
2024-06-05Shegog ToddBuy44.70K$8.92398.72K
2024-06-05Morris ArleneBuy44.70K$8.92398.72K
2024-05-25Pinnow ColeBuy525.00K$8.224.32M
2024-05-25Pinnow ColeSell0——
2024-04-01Ferrante Karen JeanBuy3.21K$6.9022.17K
2024-03-28Fairmount Funds Management LLCBuy286.85K——
2024-03-28Fairmount Funds Management LLCBuy11.91K——
2024-03-28Fairmount Funds Management LLCSell11.91K——
2024-03-28Fairmount Funds Management LLCSell286.85K——
2024-02-16Fairmount Funds Management LLCBuy1.17M$7.508.75M
2024-02-16Fairmount Funds Management LLCBuy1.50K——
2024-01-23Robinson John EdwardBuy300.00K$4.631.39M
2024-01-23Kearns EvanBuy255.00K$4.631.18M
2024-01-23Sachs JessicaBuy300.00K$4.631.39M
2024-01-23Robbins Andrew RBuy1.10M$4.635.09M
2024-01-23Green John L.Buy300.00K$4.631.39M
2024-01-02Ferrante Karen JeanBuy3.30K$6.2420.58K
2024-01-02Ros MatthewBuy3.05K$6.2419.04K
2023-10-02Ros MatthewBuy2.17K$9.5520.72K
2023-10-02Ferrante Karen JeanBuy2.35K$9.5522.39K
2023-07-03Ferrante Karen JeanBuy1.88K$11.9622.53K
2023-07-03Ros MatthewBuy1.74K$11.9620.85K
2023-06-09Fairmount Funds Management LLCBuy800.00K$12.009.60M
2023-06-07Morris ArleneBuy36.70K$11.70429.39K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 336, holders +19 vs prior quarter. Ownership 289.53%.

HolderSharesChangeChange %Value
FMR LLC25.68M2.56M+11.06%993.86M
BLACKROCK, INC.17.35M1.31M+8.15%671.55M
VANGUARD PORTFOLIO MANAGEMENT LLC8.07M739.08K+10.08%312.40M
VANGUARD CAPITAL MANAGEMENT LLC7.41M517.37K+7.50%286.86M
STATE STREET CORP6.96M1.30M+22.98%269.54M
JUPITER TOPCO LLC6.62M6.62MNew256.42M
FAIRMOUNT FUNDS MANAGEMENT LLC5.50M00.00%212.98M
DEERFIELD MANAGEMENT COMPANY, L.P.5.01M-4.04M-44.65%193.74M
TCG CROSSOVER MANAGEMENT, LLC4.85M-92.46K-1.87%187.87M
PRICE T ROWE ASSOCIATES INC /MD/4.65M1.44M+44.82%180.06M
GEODE CAPITAL MANAGEMENT, LLC4.51M809.48K+21.88%174.53M
WELLINGTON MANAGEMENT GROUP LLP4.34M765.36K+21.39%168.11M
KYNAM CAPITAL MANAGEMENT, LP3.67M-370.23K-9.17%141.92M
LORD, ABBETT & CO. LLC3.43M249.76K+7.85%132.78M
POLAR CAPITAL HOLDINGS PLC3.23M3.23MNew125.11M
COMMODORE CAPITAL LP3.05M161.99K+5.61%118.03M
INVESCO LTD.2.61M179.51K+7.39%100.97M
WOODLINE PARTNERS LP2.60M1.09M+72.45%100.74M
PICTET ASSET MANAGEMENT HOLDING SA2.39M594.75K+33.06%92.63M
OCTAGON CAPITAL ADVISORS LP2.35M00.00%90.94M
RTW INVESTMENTS, LP2.31M-3.15M-57.70%89.36M
GOLDMAN SACHS GROUP INC2.29M-2.15M-48.39%88.57M
CANDRIAM S.C.A.2.09M572.07K+37.73%80.74M
DEEP TRACK CAPITAL, LP2.00M1.00M+100.00%77.40M
SIREN, L.L.C.1.86M150.00K+8.78%71.95M

Earnings and financials

Cogent Biosciences, Inc. (COGT) trades at $32.15, with a market cap of $5.58B and a trailing P/E of -13.52. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
63550008360000973400022499000787100000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cogent Biosciences (COGT) Financials: Revenue & Earnings

COGT$32.15+0.14 +0.42%

$5.58B

Market Cap

-13.52

P/E

37.20

Forward P/E

65

Score

Price History